Search

Search Constraints

You searched for: Author/Creator Lotem, Michal

Search Results

1. Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T Cells. Issue 2 (February 2019)

2. Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. Issue 1 (27th October 2016)

3. 672 Identification of microbial-derived HLA-bound peptides in melanoma. (9th November 2020)

4. 672 Identification of microbial-derived HLA-bound peptides in melanoma. (9th November 2020)

8. Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade. (18th May 2016)

9. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

10. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)